metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Sarcopenia as a predictor of risk of minimal hepatic encephalopathy in patients ...
Journal Information
Vol. 27. Issue S3.
Abstracts from XVII Mexican Congress of Hepatology
(December 2022)
Share
Share
Download PDF
More article options
Vol. 27. Issue S3.
Abstracts from XVII Mexican Congress of Hepatology
(December 2022)
Open Access
Sarcopenia as a predictor of risk of minimal hepatic encephalopathy in patients with liver cirrhosis
Visits
400
O Morales Gutiérrez1, A Burak Leipuner1, P Alagón Fernandez de Campo1, F Vargas Duran1, CI Hinojosa Segura1, D Montemira Orozco1, AD Santana Vargas2, MF Higuera de la Tijera1, JL Pérez Hernández1
1 Department of Gastroenterology and Hepatology. General Hospital of Mexico “Dr. Eduardo Liceaga”. Mexico City, Mexico
2 Sleep Disorders Clinic. General Hospital of Mexico “Dr. Eduardo Liceaga”. Mexico City, Mexico
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Download PDF
Statistics
Figures (2)
Special issue
This article is part of special issue:
Vol. 27. Issue S3

Abstracts from XVII Mexican Congress of Hepatology

More info
Introduction and Objective

Sarcopenia, defined as loss of muscle mass and strength, and minimal hepatic encephalopathy (MHE), alter the quality of life and prognosis of patients with cirrhosis. Ammonia plays a key role in the pathogenesis of MHE and has been associated with decreased muscle mass and strength. However, the relationship between sarcopenia and MHE is not well defined. The objective of this study was to determine their relationship and identify predictors of MHE.

Materials and Methods

Prospective study, including 96 patients with compensated cirrhosis diagnosed by transitional elastography. The presence of MHE and sarcopenia was determined by a critical flicker frequency test and standard from the European Working Group EWGSOP2. Muscle mass and strength were determined by electrical bioimpedance and a handgrip dynamometer. Functional capacity was evaluated by a Short Physical Performance Battery (SPPB), performing linear logistic regression analysis to identify predictors of MHE. The trial was approved by the research ethics committee, and informed consent was obtained.

Results

Of the ninety-six patients with cirrhosis, 61 (64%) and 35 (36.5%) were diagnosed with MHE and sarcopenia, respectively. In the multivariate analysis, the SPPB rating (R 0.521, 95% CI 0.85-2.54, p=<0.001) and grip strength (R 0.314, 95% CI 0.024-0-50, p=0.032) showed the highest predictive value for MHE. (Table 1 and Figure 1).

Conclusions

Decreased handgrip strength and SPPB score were significant predictors of MHE. Early nutritional intervention and physical rehabilitation could reduce the risk of developing EHM in patients with cirrhosis.

Funding

Donation by the volunteer ladies of the Hospital General de México “Dr. Eduardo Liceaga.”

Declaration of interest

The authors declare no potential conflicts of interest.

Full Text

Table 1. Demographic distribution by frequencies, difference in means and proportions of subjects with liver cirrhosis by gender (n=96).

Figure 1. Simple dispersion diagram. Logistic regression analysis. SPPB and handgrip score associated with Flicker score.

Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos